Feedback / Questions
luveltamab tazevibulin (STRO-002) - Sutro Biopharma
https://www.globenewswire.com/news-release/2024/05/13/2880903/0/en/Sutro-Biopharma-Reports-First-Quarter-2024-Financial-Results-Business-Highlights-and-Select-Anticipated-Milestones.html
May 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next